Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02632422 · ClinicalTrials.gov registry record · NA

AIH-induced Walking Recovery After Subacute SCI

A NA study of Spinal Cord Injury, sponsored by Spaulding Rehabilitation Hospital.

Active
Registry status
NA
Development phase
125
Enrollment target
2
Study locations

NCT02632422 is a NA study of Spinal Cord Injury that is active but no longer recruiting, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 125 participants, above the 85-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (47% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02632422, a NA study of Spinal Cord Injury, is active but no longer recruiting, sponsored by Spaulding Rehabilitation Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
125 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to determine how mild breathing bouts of low oxygen may restore walking and leg strength in persons who have sustained a spinal cord injury.

Conditions Studied

Interventions

  • OTHER Walking
  • OTHER Daily acute intermittent hypoxia (dAIH)
  • OTHER dSHAM

Study Locations (2)

Georgia

  • Shepherd Center - Atlanta

Massachusetts

  • Spaulding Rehabilitation Hospital - Cambridge

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2015-10
Est. Completion 2027-12-30
Phase NA

Sponsor

Spaulding Rehabilitation Hospital

101 total trials

What the Registry Record Tells You About NCT02632422

The ClinicalTrials.gov registry entry for NCT02632422 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 85-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (47% higher). The listed sponsor is Spaulding Rehabilitation Hospital, which has 101 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Spinal Cord Injury appearing as the primary indexed condition, and to 3 interventions - of which Walking is the first listed.

NCT02632422 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Georgia, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02632422 about?

NCT02632422 is a clinical study titled "AIH-induced Walking Recovery After Subacute SCI". The purpose of this study is to determine how mild breathing bouts of low oxygen may restore walking and leg strength in persons who have sustained a spinal cord injury.

What is the current status of trial NCT02632422?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2015-10. Estimated completion is 2027-12-30.

What conditions does trial NCT02632422 study?

This clinical trial studies the following conditions: Spinal Cord Injury.

What interventions are being tested in trial NCT02632422?

The interventions under investigation include: Walking (OTHER), Daily acute intermittent hypoxia (dAIH) (OTHER), dSHAM (OTHER).

Who is sponsoring clinical trial NCT02632422?

This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02632422 being conducted?

This trial has 2 study locations across Georgia, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.